Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Little Green Pharma Ltd. ( (AU:LGP) ) is now available.
Little Green Pharma Ltd reported a revenue increase to over $10 million for the quarter ending September 2025, marking a growth of over 10% from the previous quarter. The company achieved significant sales in Germany, particularly with its CherryCo products, and has implemented cost-saving measures through automation and offshoring. The completion of a TGA consultation period is expected to lead to regulatory reforms that could benefit the company. Additionally, Little Green Pharma has expanded its production capacity in Denmark and launched a new distribution service in Victoria, Australia.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is a company operating in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company is involved in the cultivation and manufacturing of cannabis-based medicines, with a market focus on regions such as Germany and Australia.
Average Trading Volume: 203,770
Technical Sentiment Signal: Buy
Current Market Cap: A$41.26M
Find detailed analytics on LGP stock on TipRanks’ Stock Analysis page.